Friday, December 21, 2012

Massachusetts lawmaker seeks greater pharmacy regulation | Essentials

Massachusetts lawmaker seeks greater pharmacy regulation

Silk Road Covered Bridge - Bennington, Vermont
Silk Road Covered Bridge - Bennington, Vermont by Dougtone
License (according to Flickr): Attribution-ShareAlike License
Excerpt:

FRAMINGHAM, Mass. -- A Massachusetts lawmaker states he'll introduce legislation to enhance federal oversight of specialty pharmacies like the one linked to a dangerous meningitis episode. Democratic U.S. Rep. Ed Markey made the announcement Thursday outside the now-closed New England Compounding Center in Framingham. A tainted steroid made by the center triggered a fungal meningitis episode linked to 28 deaths across the nation. Compounding pharmacies custom-mix solutions that normally aren't commercially readily available. They aren't controlled by the U.S. Food and Drug Administration. Under Markey's legislation, to be introduced Friday, such pharmacies would be FDA-regulated, if they produce bigger volumes of a medication for basic circulation. Officials state that's what the company appeared to be doing, though they were only permitted to produce patient-specific prescriptions. The expense also requires pharmacies to label compounded drugs to show they have not been FDA-tested.

People:

Rep. Ed Markey

Overall Sentiment: 0.0980361

Relevance: 0.921907

Disambiguation: Politician | U.S.CongresspersonReferences:

Additional Info:

StateOrCounty: Mass.

Overall Sentiment: 0.0152498

Relevance: 0.360534

Disambiguation: Location | PoliticalDistrict | AdministrativeDivision | GovernmentalJurisdiction | USStateReferences:

Country: U.S.

Overall Sentiment: 0.0370664

Relevance: 0.316882

Disambiguation: Location | Region | AdministrativeDivision | GovernmentalJurisdiction | FilmEditorReferences:

HealthCondition: meningitis

Overall Sentiment: -0.798654

Relevance: 0.745922

Organization: U.S. Food and Drug Administration

Overall Sentiment: 0.0206927

Relevance: 0.50203

URL Meta Details

No comments:

Post a Comment